Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.19%) to 8806.53, DAX +1.20% to 24073.67, CAC40 +0.35% to 7723.47, STOXX 600 +0.44% to 543.50

Jul 07 ,2025

  • Synopsis:

    • European equity markets ended mixed with pan-European indices closing just below best levels. Germany +1.2% followed by Italy and Spain both up ~ +0.7% led outperformers. Denmark (1.1%), Portugal (0.8%) and Finland (0.5%) led underperformers.

    • Attention on trade ahead of 9-Jul deadline. President Trump said will begin sending out tariff letters and/or announcing trade deals from midday 7-Jul, earlier repeating US would be setting 'take it or leave it' terms. Treasury Secretary Bessent warned tariffs to revert to 'Liberation Day'/steeper levels though also signaled some leeway with levies taking effect 1- Aug. Said focus is on 18 major partners and several big agreements are close. EU still weighing up whether to accept a provisional trade deal that would maintain 10% on most exports. In addition to baseline tariff, conversations would continue on providing relief to specific sectors, such as cars. Talks said to be progressing. Meanwhile, latest reports suggest US difficulties reaching agreement with Japan, South Korea and India.

    • On macro data front, Eurozone ZEW investor sentiment better than expected in July update. German industrial production beat expectations and another UK house price update pointed to slowdown after tax changes. Meanwhile, survey showed UK firms' appetite to hire at 13-year low, though UK has jumped in the ranks of best investment destination. More downbeat narrative surrounding UK government's pro-business policies. Weekend press discussed likely tax rises after Chancellor Reeves said there are costs to recent welfare reform U-turn.

    • In other news, Trump threatened additional 10% tariffs on countries that align with BRICS. China-EU trade tensions continue to simmer after Beijing imposed anti-dumping duties on European brandy while moving to block EU companies from participating in medical device procurement tenders. Trump sounded positive on prospects for TikTok deal with China talks beginning Monday or Tuesday.

    • In corporate news, Capgemini (CAP.FP) agreed to acquire WNS (Holdings) for $3.3B in cash. Company also updated on Q2 and H2 performance. Shell (SHEL.LN) issued disappointed Q2 update note ahead of results on 31-Jul. Ferrexpo (FXPO.LN) posted sequential fall of 40.4% in Q2 iron ore production, hurt by suspension of VAT refunds. Out of the Nordics, Clas Ohlson (CLAS.B.SS) reported 26th consecutive month of robust organic sales growth, with Jun sales up 10% y/y in local currency.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Technology +1.32%, Banks +1.28%, Financial Svcs +1.23%, Travel & Leisure +1.10%, Insurance +1.09%, Ind Goods & Svcs +1.01%, Construct & Mtls +0.79%, Media +0.63%, Persnl & HHold Goods +0.55%

      • Underperformers

        • Oil & Gas (1.26%), Utilities (0.84%), Health Care (0.77%), Food & Beverage (0.74%), Real Estate(0.37%), Chemicals (0.24%), Basic Resources (0.20%), Telecom (0.05%), Autos & Parts +0.18%, Retail +0.30%

    • Macro/Peripheral markets:

      • EU

        • Eurogroup statement on the fiscal stance for the euro area in 2026 - release

        • Paschal Donohoe confirmed for a third term as Eurogroup President - release

      • Geopolitics

        • EU faces Trump's tariff hike as trade deal hopes fade - Reuters, AP, Guardian, ABC

        • Trump escalates trade war with 17% tariff threat on EU food - FT

        • EU plans critical mineral stockpiles to bolster resilience - FT

        • China restricts EU medical device imports amid trade tensions - link

        • France pushes EU to bolster tariffs against Chinese imports - Bloomberg

        • EU sticks to Trump's 9 July tariff deadline despite US extension hints - Euractiv

        • Trump Sets 1-Aug Tariff Start Ahead of Wednesday Deadline - Bloomberg

      • UK

        • British firms pivot from US investment as tariffs loom - Reuters

        • Starmer's Labour struggles as Reform UK gains in polls - London Times

        • Reeves urged to raise taxes to fund Labour's growth plans - Independent

        • Forcing pensions into British assets like 'capital controls', says Lloyds boss - FT

        • Wealthy Britons exit UK over Labour's tax crackdown - FT

        • UK hospitality reels as tax hikes trigger job losses - London Times

        • Global Combat Air Program (GCAP) - a joint initiative between the UK, Japan and Italy to develop a next-generation fighter jet, opens HQ in UK - release; Italy, Japan, UK defence ministers reaffirm commitment to the program - release; joint statement

      • France

        • Macron's gamble: Will France see another snap election? - Politico

      • Germany

        • German pension fund bets on Chinese equities with $50M mandate - Bloomberg

        • Germany eyes €4B to boost industry competitiveness - FT

      • Ireland

        • Q2 national asking prices +7% y/y; Improvement in home completions is likely in 2025 - MyHome Property Report

        • Donohoe set for re-election as EuroGroup President - RTE; Irish Times

        • Ireland central bank's Makhlouf remarks at Les Rencontres Économiques over the weekend - release

      • Greece

        • Greece is bridging its investment gap, Bank of Greece Governor Stournaras says - ekathimerini

      • Norway

        • Now prudent to start phasing out the 2G network says National Communications Authority (Nkom) - release

    • Company news:

      • Notable Gainers

        • +9.6% IDEX.NO (IDEX Biometrics NOK3.67, +0.32)

        • +4.7% CAMX.SS (Camurus SEK675.50, +30.50) -- DNB Carnegie upgrade

        • +3.9% NAS.NO (Norwegian Air Shuttle NOK15.18, +0.57) -- ABG Sundal Collier upgrade

        • +2.1% PINE.LN (Pinewood Technologies Group £4.67, +0.09) -- acquires customer contracts for £2.5M

      • Notable Decliners

        • -13.4% PANR.LN (Pantheon Resources £0.21, -0.03) -- raises $16.25M by way of a conditional placing and subscriptions of new Ordinary Shares

        • -11.0% INTRUM.SS (Intrum SEK60.08, -7.46)

        • -8.7% RECSI.NO (REC Silicon NOK2.14, -0.20) -- board update on Hanwha Offer

        • -6.0% ATRLJ.B.SS (Atrium Ljungberg SEK32.91, -2.09) -- Handelsbanken downgrade; Kepler Cheuvreux downgrade

        • -5.7% CURY.LN (Currys £1.17, -0.07) -- RBC Capital Markets downgrade

        • -5.4% KID.NO (Kid ASA NOK148.60, -8.40) -- prelim. Q2 revenue

        • -5.1% CAP.FP (Capgemini €137.80, -7.35) -- acquires WNS for $3.3B; updates on Q2 and H2 performance

        • -4.5% METSB.FH (Metsa Board €3.11, -0.15) -- prelim. Q2 earnings

        • -2.8% DORO.SS (Doro SEK36.15, -1.05) -- CEO replaced

        • -2.1% KRN.GR (Krones €137.40, -3.00) -- Oddo downgrade

        • -1.7% STLAM.IM (Stellantis €8.43, -0.15) -- BofA downgrade

        • -1.5% FXPO.LN (Ferrexpo £0.48, -0.01) -- Q2 production report

    • EU companies reporting tomorrow:

      • Earnings:

        • Nordics: Industrivarden (INDU.A.SS), Atrium Ljungberg (ATRLJ.B.SS), Kinnevik (KINV.B.SS), ABG Sundal Collier Holding (ABG.NO), Admicom (ADMCM.FH)

        • UK: Optima Health (OPT.LN), Begbies Traynor Group (BEG.LN), Celebrus Technologies (CLBS.LN), Synectics (SNX.LN)

  • Data:

    • Economics:

      • Germany May industrial production +1.2% m/m vs consensus (0.6%), prior revised (1.6%) from (1.4%)

      • UK Jun house price index +2.5% y/y vs consensus +2.2%, prior revised +2.6% from +2.5% - Halifax

      • Sweden Jun preliminary CPI +0.8% y/y vs consensus +0.4%, prior +0.2%

      • Denmark May manufacturing production +0.1% m/m vs consensus (1.2%), prior revised +2.1% from +2.0%

      • Norway May manufacturing production (1.7%) m/m vs consensus (1.0%), prior revised +2.9% from +2.8%

      • Eurozone

        • Jul investor confidence +4.5 vs consensus +1.1, prior +0.2 - Sentix

        • May retail sales +1.8% y/y vs consensus +1.2%, prior revised +2.7% from +2.3%

    • Markets:

      • WTI Crude (Apr 25): ($68.37) or (100.00%) to $0.00

      • €-$ (0.0047) or (0.40%) to 1.1737

      • £-$ (0.0016) or (0.12%) to 1.3642

      • €-£ (0.0026) to 0.8602

      • S&P 500 +6.70%

        • Performance year-to-date

        • FTSE 100: +7.74%

        • DAX: +20.75%

        • CAC: +4.59%

        • MIB: +16.73%

        • Stoxx 600: +7.02%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE